5.4 Professional Scope of Practice and Prescriptive Authority

The APRN Consensus Model and LACE Framework

The Consensus Model for APRN Regulation: Licensure, Accreditation, Certification, and Education (LACE) was developed by the National Council of State Boards of Nursing (NCSBN) and over 40 nursing organizations. Its overarching goal is to align state nurse practice acts to establish national regulatory uniformity, enabling APRNs to practice to the full extent of their academic preparation and clinical training without unnecessary administrative barriers.

• Licensure (L): Granted by individual State Boards of Nursing, conferring legal authority to practice as an Advanced Practice Registered Nurse.
• Accreditation (A): Formal evaluation and approval of APRN educational programs by national accrediting bodies such as the Commission on Collegiate Nursing Education (CCNE) or the Accreditation Commission for Education in Nursing (ACEN).
• Certification (C): Psychometrically validated national certification examination administered by an accredited credentialing organization (e.g., the American Nurses Credentialing Center [ANCC] PMHNP-BC examination) validating entry-level clinical competency.
• Education (E): Formal graduate-level nursing education (Master of Science in Nursing [MSN] or Doctor of Nursing Practice [DNP]) or post-graduate certificate preparation from an accredited university.

Under the Consensus Model, the PMHNP role is defined as a broad, lifespan population focus (Psychiatric-Mental Health Across the Lifespan), covering pediatric, adolescent, adult, and geriatric populations. The PMHNP scope of practice encompasses comprehensive mental health care, including physical assessment of psychiatric presentations, differential diagnosis, ordering and interpreting laboratory and diagnostic tests, psychopharmacology management, individual, family, and group psychotherapies, crisis intervention, and interprofessional consultation.

State Practice Environments

Despite the national standardization advocated by the Consensus Model, individual State Nurse Practice Acts govern actual clinical scope of practice. The American Association of Nurse Practitioners (AANP) categorizes state regulatory environments into three distinct practice designations:

1. Full Practice: State practice and licensure laws permit all NPs to evaluate patients, diagnose, order and interpret diagnostic tests, and initiate and manage treatments, including prescribing medications and controlled substances, under the exclusive regulatory authority of the State Board of Nursing. No collaborative practice agreement, physician supervision, or mandate for outside oversight is required. Currently, 27 states and U.S. territories have adopted Full Practice authority.
2. Reduced Practice: State practice laws reduce the ability of NPs to engage in at least one element of NP practice. The state mandates a regulated Collaborative Practice Agreement (CPA) with a collaborating physician in order for the NP to provide patient care or prescribe specific classes of medications (12 states).
3. Restricted Practice: State laws restrict the ability of NPs to engage in at least one element of NP practice. State law mandates career-long physician supervision, delegation, or direct team management in order for the NP to provide patient care or maintain prescriptive authority (11 states).

Collaborative Practice Agreements (CPAs)

In states designated as reduced or restricted, PMHNPs must maintain a valid, signed Collaborative Practice Agreement (CPA) with a licensed physician. The CPA is a formal legal contract specifying:

• The delegated prescriptive authority protocols and any restriction on specific controlled substance schedules.
• Mandatory chart review requirements (e.g., random monthly audits of 10% to 20% of patient records by the collaborating physician).
• Specific consultation protocols for complex clinical cases, acute hospitalizations, or high-dose polypharmacy.
• Distance and geographic proximity limitations (e.g., requiring the collaborating physician's practice site to be within 50 miles of the PMHNP's practice location).
• Mandatory emergency coverage plans during physician or NP absence.

CPAs must be updated annually, maintained on-site at the practice facility, and submitted to the State Board of Nursing or Board of Medicine upon request. Practicing without an active CPA in a reduced or restricted state constitutes unauthorized practice and grounds for immediate license revocation.

Prescriptive Authority and DEA Controlled Substance Schedules

Prescriptive authority is the legal right of a qualified clinician to prescribe legend drugs and controlled substances. While all 50 states grant PMHNPs prescriptive authority for legend (non-controlled) medications, controlled substance prescribing is regulated under both state law and the federal Controlled Substances Act (CSA) administered by the Drug Enforcement Administration (DEA).

To prescribe controlled substances, a PMHNP must possess an active RN license, APRN license, state controlled substance registration (in states where required), and a valid DEA registration number. Controlled substances are classified into five schedules based on medical utility and abuse liability:

Federal Prescribing Rules for Schedule II Medications

Prescribing Schedule II stimulants (e.g., methylphenidate or amphetamine salts for ADHD) involves the strictest federal regulations:

• Zero Refills: Refills are strictly illegal under federal law. Every fill requires a separate, unique prescription.
• Electronic Prescribing for Controlled Substances (EPCS): Federal mandates (including the SUPPORT Act) require prescribers to issue Schedule II prescriptions electronically using software certified for EPCS with two-factor identity authentication.
• Emergency Verbal Prescriptions: In an acute emergency, a PMHNP may issue an oral Schedule II prescription to a pharmacy for a quantity sufficient to cover the emergency period (max 72 hours). The PMHNP must deliver a written or EPCS follow-up prescription to the pharmacy within 7 days with the notation "Authorization for Emergency Dispensing."
• Multiple Prescriptions for 90-Day Supply: A PMHNP may issue up to three separate Schedule II prescriptions on the same day authorizing a patient to receive up to a 90-day total supply, provided each prescription clearly specifies the earliest date on which the pharmacy may fill the prescription (e.g., "Do not fill before [Date]").

Prescription Drug Monitoring Programs (PDMPs)

State-administered PDMPs are electronic databases that collect state-wide dispensing data for Schedule II through V controlled substances. PMHNPs are legally mandated to query the PDMP before initiating any controlled substance prescription (especially stimulants or benzodiazepines) and at mandatory follow-up intervals (typically every 3 to 6 months). PDMPs allow clinicians to:

• Identify red-flag behaviors such as "doctor shopping" or multiple simultaneous prescribers.
• Prevent dangerous co-prescribing combinations (e.g., concurrent opioid and benzodiazepine prescriptions, which carry a black box warning for fatal respiratory depression).
• Detect diversion and verify patient medication adherence.

Credentialing, Privileging, and ANCC Recertification

• Credentialing: The process by which healthcare organizations and insurance networks verify a clinician's professional qualifications, including university transcripts, active RN/APRN licenses, national certification, DEA registration, and malpractice claim history.
• Privileging: The process by which a hospital board or clinical facility authorizes a provider to perform specific diagnostic, therapeutic, or clinical procedures (e.g., admitting patients, ordering ECT) based on verified credentials.
• ANCC PMHNP-BC Recertification: The ANCC national board certification is valid for a 5-year cycle. To recertify, the PMHNP must maintain an active, unencumbered RN/APRN license and fulfill specific professional development criteria, including:
  • 75 continuing education (CE) hours directly related to the PMHNP specialty, of which at least 25 hours must be in advanced pharmacotherapeutics.
  • Completion of at least 1,000 clinical practice hours within the 5-year certification period OR completion of an approved academic or professional portfolio category.

---

ANA Scope and Standards of Practice: Psychiatric-Mental Health Nursing

The ANCC Ethics, Legal Principles, and Cultural Care domain explicitly includes the ANA Scope and Standards of Practice: Psychiatric-Mental Health Nursing. These standards define the competent PMHNP role across the lifespan and anchor professional accountability beyond state nurse practice acts alone.

Scope of Practice Anchors

• Population focus: Psychiatric-mental health care across the lifespan (infant through frail elderly), including prevention, assessment, diagnosis, treatment, and recovery support.
• Advanced practice competencies: Comprehensive psychiatric evaluation, differential diagnosis, pharmacologic and nonpharmacologic intervention, psychotherapy, consultation, and interprofessional collaboration.
• Standards of practice: Assessment, diagnosis, outcomes identification, planning, implementation (coordination of care, health teaching/promotion, consultation, prescriptive authority and treatment), and evaluation.
• Standards of professional performance: Ethics, culturally congruent practice, communication, collaboration, leadership, education, evidence-based practice/research, quality of practice, professional practice evaluation, resource utilization, and environmental health.

On board items, apply these standards when a vignette asks what action is consistent with professional nursing standards—e.g., documenting outcomes, using evidence-based interventions, providing health teaching, maintaining cultural humility, and evaluating response to treatment. State Nurse Practice Acts set legal authority; ANA standards set the professional practice bar.